Kenvue Inc. $KVUE Shares Purchased by Texas Yale Capital Corp.

Texas Yale Capital Corp. raised its holdings in Kenvue Inc. (NYSE:KVUE) by 204.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 72,325 shares of the company’s stock after purchasing an additional 48,575 shares during the quarter. Texas Yale Capital Corp.’s holdings in Kenvue were worth $1,174,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Salomon & Ludwin LLC acquired a new stake in shares of Kenvue in the 3rd quarter valued at approximately $25,000. NBT Bank N A NY grew its holdings in Kenvue by 180.3% during the third quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock worth $25,000 after acquiring an additional 1,006 shares during the period. Cornerstone Planning Group LLC raised its position in Kenvue by 705.2% in the third quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock worth $25,000 after acquiring an additional 1,361 shares in the last quarter. Golden State Wealth Management LLC lifted its holdings in Kenvue by 150.1% in the third quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company’s stock valued at $32,000 after acquiring an additional 1,190 shares during the period. Finally, Trust Co. of Vermont lifted its holdings in Kenvue by 50.9% in the third quarter. Trust Co. of Vermont now owns 2,385 shares of the company’s stock valued at $39,000 after acquiring an additional 804 shares during the period. Institutional investors and hedge funds own 97.64% of the company’s stock.

Insiders Place Their Bets

In related news, Director Jeffrey C. Smith purchased 3,200,000 shares of the business’s stock in a transaction dated Friday, December 12th. The stock was bought at an average cost of $17.37 per share, with a total value of $55,584,000.00. Following the completion of the acquisition, the director directly owned 27,307,632 shares in the company, valued at $474,333,567.84. The trade was a 13.27% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.17% of the company’s stock.

Wall Street Analyst Weigh In

KVUE has been the subject of several recent analyst reports. Evercore set a $18.00 price objective on shares of Kenvue in a research note on Tuesday, October 28th. Jefferies Financial Group downgraded shares of Kenvue from a “buy” rating to a “hold” rating and reduced their price target for the company from $23.00 to $18.00 in a research report on Friday, January 30th. Zacks Research raised Kenvue from a “strong sell” rating to a “hold” rating in a research note on Wednesday, November 26th. Johnson Rice reaffirmed a “neutral” rating on shares of Kenvue in a research note on Tuesday, October 28th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Kenvue in a research report on Friday, January 9th. Four analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the stock. According to MarketBeat.com, Kenvue presently has an average rating of “Hold” and an average target price of $19.46.

Kenvue Stock Up 0.8%

KVUE stock opened at $18.70 on Tuesday. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.69. The company’s 50 day simple moving average is $17.42 and its 200-day simple moving average is $17.68. Kenvue Inc. has a 12 month low of $14.02 and a 12 month high of $25.17. The firm has a market capitalization of $35.82 billion, a PE ratio of 24.93 and a beta of 0.59.

Kenvue Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, February 25th. Shareholders of record on Wednesday, February 11th will be given a dividend of $0.2075 per share. The ex-dividend date of this dividend is Wednesday, February 11th. This represents a $0.83 annualized dividend and a yield of 4.4%. Kenvue’s dividend payout ratio (DPR) is presently 110.67%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.